Top stories

ESG & SustainabilityAfrica’s sustainable fashion future to be unveiled at Twyg’s Africa Textile Talks
12 hours

Marketing & MediaCMOs struggle with fragmented “Frankenstack” environments and integration challenges
2 days




More news


As part of Roche's Technology Transfer Initiative, these companies will be provided free of charge with the technical expertise and guidance to manufacture generic HIV medicine, based upon the processes to produce saquinavir, Roche's 2nd line1 HIV medicine.
To read the rest of the article, click here